Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

NCT05675449

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Clinical Research Advisors (Encino Satellite Location) Encino, California, United States
  • Clinical Research Advisors (Korea Town Satellite Location) Los Angeles, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05572515

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
View all 211 locations
View Trial Details
Active, Not Recruiting

Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)

NCT02386670

Conditions
Cognition Disorders, Cognitive Dysfunction, Depressive Disorder, +13 more
Locations
  • Baycrest Centre for Geriatric Care Toronto, Ontario, Canada
  • Centre for Addiction and Mental Health Toronto, Ontario, Canada
  • St. Michael's Hospital Toronto, Ontario, Canada
  • Sunnybrook Heath Sciences Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

NCT04404660

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Diego Health (UCSD) La Jolla, California, United States
  • University of California Davis (UC Davis) Sacramento, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

NCT04684108

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hostipal Beijing, Beijing Municipality, China
  • Shenzhen Second People's Hospital Shenzhen, Guangzhou, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2)

NCT03703050

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Hôpital Trousseau Paris, France
  • Gustave Roussy Villejuif, Val de Marne, France
  • CHU Bordeaux Hopital Pellegrin Bordeaux, France
View all 13 locations
View Trial Details

Related conditions